Barings LLC Exelixis, Inc. Transaction History

Barings LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$18.39 - $24.8 $185,720 - $250,455	-10,099 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$20.67 - $26.94 $208,746 - $272,067	10,099 New	10,099 $247,000
Q4 2019 Feb 14, 2020	SELL	$15.15 - $18.89 $566,610 - $706,486	-37,400 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$18.93 - $24.75 $5,679 - $7,425	300 Added 0.81%	37,400 $799,000
Q1 2019 May 08, 2019	BUY	$19.6 - $24.76 $727,160 - $918,596	37,100 New	37,100 $883,000

460

246M

1.7M

1.02M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $7.11B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Barings LLC, based on Form 13F filings with the SEC.

Stay updated on Barings LLC with notifications on news.